HomeCompareCHME vs GBDC

CHME vs GBDC: Dividend Comparison 2026

CHME yields 19801.98% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHME wins by $1130384.89M in total portfolio value
10 years
CHME
CHME
● Live price
19801.98%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1130405.67M
Annual income
$101,177,204,557.67
Full CHME calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — CHME vs GBDC

📍 CHME pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHMEGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHME + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CHME pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHME
Annual income on $10K today (after 15% tax)
$1,683,168.32/yr
After 10yr DRIP, annual income (after tax)
$86,000,623,874.02/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, CHME beats the other by $85,986,693,000.12/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHME + GBDC for your $10,000?

CHME: 50%GBDC: 50%
100% GBDC50/50100% CHME
Portfolio after 10yr
$565213.22M
Annual income
$50,596,796,910.53/yr
Blended yield
8.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

CHME
No analyst data
Altman Z
1.8
Piotroski
6/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHME buys
0
GBDC buys
2
PoliticianChamberTickerTypeAmountDate
David P. Joyce🏢 House$GBDC▼ Sell$1,001 - $15,0002023-06-30
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002023-06-19
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-14
David P. Joyce🏢 House$GBDC▼ Sell$15,001 - $50,0002022-07-12
Teresa Leger Fernandez🏢 House$GBDC▼ Sell$15,001 - $50,0002021-01-20
David P. Joyce🏢 House$GBDC▲ Buy$1,001 - $15,0002020-02-25
David P. Joyce🏢 House$GBDC▲ Buy$15,001 - $50,0002019-05-30
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHMEGBDC
Forward yield19801.98%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%51.1%
Portfolio after 10y$1130405.67M$20.78M
Annual income after 10y$101,177,204,557.67$16,389,263.41
Total dividends collected$955841.06M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: CHME vs GBDC ($10,000, DRIP)

YearCHME PortfolioCHME Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$1,000,799$990,099.01$12,490$1,790.28+$988.3KCHME
2$47,374,131$46,303,276.11$16,522$3,157.73+$47.36MCHME
3$1,074,908,161$1,024,217,841.10$23,578$5,898.68+$1074.88MCHME
4$12,009,622,648$10,859,470,915.11$37,115$11,886.75+$12009.59MCHME
5$69,546,358,216$56,696,061,982.96$66,136$26,423.57+$69546.29MCHME
6$227,835,371,365$153,420,768,073.78$137,257$66,491.44+$227835.23MCHME
7$478,648,216,202$234,864,368,841.84$341,734$194,868.54+$478647.87MCHME
8$742,721,392,306$230,567,800,969.61$1,050,788$685,133.02+$742720.34MCHME
9$961,895,759,073$167,183,869,305.91$4,099,314$2,974,971.01+$961891.66MCHME
10$1,130,405,666,766$101,177,204,557.67$20,775,530$16,389,263.41+$1130384.89MCHME

CHME vs GBDC: Complete Analysis 2026

CHMEStock

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

Full CHME Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this CHME vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHME vs SCHDCHME vs JEPICHME vs OCHME vs KOCHME vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.